| ACCP | American College of Chest Physicians |
| AHA | American Heart Association |
| BNP | Brain natriuretic peptide |
| CDT | Catheter directed therapy |
| CT | Computed tomography |
| CTA | Computed tomography angiogram |
| DVT | Deep vein thrombosis |
| ECMO | Extracorporeal membrane oxygenation |
| ESC | European Society of Cardiology |
| FLARE | FlowTriever Pulmonary Embolectomy clinical study |
| FLASH | FlowTriever All-Comer Registry for Patient Safety and Hemodynamics |
| h-FABP | Heart-type fatty acid binding protein |
| ICOPER | International Cooperative Pulmonary Embolism Registry |
| IVC | Inferior vena cava |
| LMWH | Low molecular weight heparin |
| NO | Nitric oxide |
| NT-proBNP | N-terminal pro-brain natriuretic peptide |
| OPTALYSE | Optimal duration of requested pulse thrombolysis procedure and acute intermediate-risk pulmonary embolism |
| PE | Pulmonary embolism |
| PEITHO | Pulmonary embolism thrombolysis |
| PERT | Pulmonary embolism response team |
| PESI | Pulmonary Embolism Severity Index |
| PREPIC2 | Prevention of recurrent pulmonary embolism by vena cava interruption 2 |
| RCT | Randomized controlled trial |
| RR | Relative risk |
| RV | Right ventricular |
| RVAD | Right ventricular assist device |
| RVD | Right ventricular dysfunction |
| SBP | systolic blood pressure |
| SEATTLE II | EkoSonic endovascular system and Activase for treatment of acute pulmonary embolism |
| sPESI | Simplified Pulmonary Embolism Severity Index |
| SUNSET sPE | Standard vs. Ultrasound-Assisted Catheter thrombolysis for Submassive Pulmonary Embolism |
| TOPCOAT | Tenecteplase or Placebo Cardiopulmonary Outcomes at Three Months |
| TAFI | Thrombin activatable fibrinolysis inhibitor |
| tPA | tissue plasminogen activator |
| ULTIMA | Ultrasound accelerated thrombolysis of pulmonary embolism |
| USAT | Ultrasound-assisted thrombolysis |